Abstract:Osteosarcoma, a malignant bone tumor predominantly affecting children and adolescents, presents significant therapeutic challenges, particularly in metastatic or recurrent cases. Conventional surgical and chemotherapeutic approaches have achieved partial therapeutic efficacy; however, the prognosis for long-term survival remains bleak. Recent studies have highlighted the imperative for a comprehensive exploration of the osteosarcoma immune microenvironment, focusing on the integration of diverse immunotherapeutic strategies—including immune checkpoint inhibitors, tumor microenvironment modulators, cytokine therapies, tumor antigen-specific interventions, cancer vaccines, cellular therapies, and antibody-based treatments—that are directly pertinent to modulating this intricate microenvironment. By targeting tumor cells, modulating the tumor microenvironment, and activating host immune responses, these innovative approaches have demonstrated substantial potential in enhancing the effectiveness of osteosarcoma treatments. Although most of these novel strategies are still in research or clinical trial phases, they have already demonstrated significant potential for individuals with osteosarcoma, suggesting the possibility of developing new, more personalized and effective treatment options. This review aims to provide a comprehensive overview of the current advancements in osteosarcoma immunotherapy, emphasizing the significance of integrating various immunotherapeutic methods to optimize therapeutic outcomes. Additionally, it underscores the imperative for subsequent research to further investigate the intricate interactions between the tumor microenvironment and the immune system, aiming to devise more effective treatment strategies. The present review comprehensively addresses the landscape of osteosarcoma immunotherapy, delineating crucial scientific concerns and clinical challenges, thereby outlining potential research directions.

Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine

The Role of CTLA-4 and PD-1 in Anti-Tumor Immune Response and Their Potential Efficacy Against Osteosarcoma

Molecular Pathogenesis and Therapeutic Strategies of Human Osteosarcoma

3D Models of Sarcomas: the Next-generation Tool for Personalized Medicine

A Self-Assembling Immune-Featured Osteosarcoma Patient/PDX Derived Organoid Model and Biobank for Personalized Immune Therapy

Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma

The generation and use of animal models of osteosarcoma in cancer research

Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma

Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment

Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress

Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies

Current Status and Prospects of Targeted Therapy for Osteosarcoma

In Vitro Osteosarcoma Models Based on 3D-Printed Composite Scaffolds to Reveal Cellular Responses, Molecular Mechanisms and Predictive Biomarkers

An osteosarcoma-on-a-chip model for studying osteosarcoma matrix-cell interactions and drug responses

Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets

Nanosized drug delivery strategies in osteosarcoma chemotherapy

Advancing therapy for osteosarcoma

Current Progress and Open Challenges for Applying Tyrosine Kinase Inhibitors in Osteosarcoma

Anti-Angiogenesis Target Therapy for Advanced Osteosarcoma

Network pharmacology, molecular docking, and molecular dynamics simulations shed light on the mechanism behind Gynostemma pentaphyllum's efficacy against osteosarcoma

Patient-derived xenograft models in musculoskeletal malignancies